HYPNION
Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities. Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’ impact on sleep and wake parameters. Hypnion is acquired by Eli Lilly and Company. Hypnion was founded in 2000 and is based in Worcester, Massachusetts.
HYPNION
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2000-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.hypnion.com
Total Employee:
51+
Status:
Closed
Contact:
(781)778-0300
Total Funding:
78 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Avammune Therapeutics
Avammune Therapeutics is a drug discovery company.
Biolink Group
Biolink Group is a life science drug discovery company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
DanioLabs
DanioLabs is a private UK drug discovery company.
Felicitex Therapeutics
Felicitex Therapeutics is a drug discovery company
Current Advisors List
Investors List
Mintz Levin
Mintz Levin investment in Series B - Hypnion
Gimv
Gimv investment in Series B - Hypnion
JAFCO Asia
JAFCO Asia investment in Series B - Hypnion
Flagship Pioneering
Flagship Pioneering investment in Series B - Hypnion
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Hypnion
Forward Ventures
Forward Ventures investment in Series B - Hypnion
MPM Capital
MPM Capital investment in Series B - Hypnion
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series B - Hypnion
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Hypnion
SR One
SR One investment in Series B - Hypnion
